IDH1 and central nervous system cancer: A comparative study on IDH mutation status reveals that the presence of contrast enhancement in diffuse IDH wild-type gliomas had no significant impact on survival, whereas its presence is associated with a poorer prognosis in IDH-mutant gliomas [26].